{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:13:35Z","timestamp":1788362015634,"version":"build-2803163510"},"reference-count":161,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005802","name":"Ministerul Cercet\u0103rii \u0219i Inov\u0103rii","doi-asserted-by":"publisher","award":["PNIII.P2-2.1-PED-2019-3141, contract no 382\/2020; grant no. PN 19.29.01.04 (Core Programm); COP A 1.2.3., grant ID:P_40_197\/2016"],"award-info":[{"award-number":["PNIII.P2-2.1-PED-2019-3141, contract no 382\/2020; grant no. PN 19.29.01.04 (Core Programm); COP A 1.2.3., grant ID:P_40_197\/2016"]}],"id":[{"id":"10.13039\/501100005802","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Glioblastoma (GBM) is one of the most aggressive tumors of the central nervous system, characterized by a wide range of inter- and intratumor heterogeneity. Accumulation of fatty acids (FA) metabolites was associated with a low survival rate in high-grade glioma patients. The diversity of brain lipids, especially polyunsaturated fatty acids (PUFAs), is greater than in all other organs and several classes of proteins, such as FA transport proteins (FATPs), and FA translocases are considered principal candidates for PUFAs transport through BBB and delivery of PUFAs to brain cells. Among these, the CD36 FA translocase promotes long-chain FA uptake as well as oxidated lipoproteins. Moreover, CD36 binds and recognizes thrombospondin-1 (TSP-1), an extracellular matrix protein that was shown to play a multifaceted role in cancer as part of the tumor microenvironment. Effects on tumor cells are mediated by TSP-1 through the interaction with CD36 as well as CD47, a member of the immunoglobulin superfamily. TSP-1\/CD47 interactions have an important role in the modulation of glioma cell invasion and angiogenesis in GBM. Separately, FA, the two membrane receptors CD36, CD47, and their joint ligand TSP-1 all play a part in GBM pathogenesis. The last research has put in light their interconnection\/interrelationship in order to exert a cumulative effect in the modulation of the GBM molecular network.<\/jats:p>","DOI":"10.3390\/ijms23020604","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T01:15:26Z","timestamp":1641518126000},"page":"604","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Fatty Acids, CD36, Thrombospondin-1, and CD47 in Glioblastoma: Together and\/or Separately?"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2122-0235","authenticated-orcid":false,"given":"Cristiana","family":"Tanase","sequence":"first","affiliation":[{"name":"Victor Babes National Institute of Pathology, 050096 Bucharest, Romania"},{"name":"Department of Cell Biology and Clinical Biochemistry, Faculty of Medicine, Titu Maiorescu University, 031593 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8122-1096","authenticated-orcid":false,"given":"Ana Maria","family":"Enciu","sequence":"additional","affiliation":[{"name":"Victor Babes National Institute of Pathology, 050096 Bucharest, Romania"},{"name":"Department of Cell Biology and Histology, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5507-1020","authenticated-orcid":false,"given":"Elena","family":"Codrici","sequence":"additional","affiliation":[{"name":"Victor Babes National Institute of Pathology, 050096 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ionela Daniela","family":"Popescu","sequence":"additional","affiliation":[{"name":"Victor Babes National Institute of Pathology, 050096 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Dudau","sequence":"additional","affiliation":[{"name":"Victor Babes National Institute of Pathology, 050096 Bucharest, Romania"},{"name":"Department of Cell Biology and Histology, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria","family":"Dobri","sequence":"additional","affiliation":[{"name":"Victor Babes National Institute of Pathology, 050096 Bucharest, Romania"},{"name":"Department of Cell Biology and Histology, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Neurology, National Institute of Neurology and Neurovascular Diseases, 077160 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevinci","family":"Pop","sequence":"additional","affiliation":[{"name":"Victor Babes National Institute of Pathology, 050096 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Mihai","sequence":"additional","affiliation":[{"name":"Victor Babes National Institute of Pathology, 050096 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ancu\u021ba-Augustina","family":"Gheorghi\u0219an-G\u0103l\u0103\u021beanu","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Histology, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"\u2018C.I. Parhon\u2019 National Institute of Endocrinology, 001863 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7740-9336","authenticated-orcid":false,"given":"Mihail Eugen","family":"Hinescu","sequence":"additional","affiliation":[{"name":"Victor Babes National Institute of Pathology, 050096 Bucharest, Romania"},{"name":"Department of Cell Biology and Histology, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/cancers6010226","article-title":"Glioblastoma multiforme: A look inside its heterogeneous nature","volume":"6","author":"Inda","year":"2014","journal-title":"Cancers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/annonc\/mdx169","article-title":"Intratumoral heterogeneity: Pathways to treatment resistance and relapse in human glioblastoma","volume":"28","author":"Qazi","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2217\/fon.14.238","article-title":"Circulating biomarker panels for targeted therapy in brain tumors","volume":"11","author":"Tanase","year":"2015","journal-title":"Future Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.semcancer.2009.02.005","article-title":"Epigenetic mechanisms in glioblastoma multiforme","volume":"19","author":"Nagarajan","year":"2009","journal-title":"Semin. Cancer Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1111\/jcmm.13781","article-title":"Long non-coding RNAs in brain tumours: Focus on recent epigenetic findings in glioma","volume":"22","author":"Pop","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/neuonc\/nov125","article-title":"Metabolic reprogramming in glioblastoma: The influence of cancer metabolism on epigenetics and unanswered questions","volume":"18","author":"Agnihotri","year":"2016","journal-title":"Neuro-Oncology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2217\/cns.13.20","article-title":"Lipid metabolism emerges as a promising target for malignant glioma therapy","volume":"2","author":"Guo","year":"2013","journal-title":"CNS Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Yu, D., Xuan, Q., Zhang, C., Hu, C., Li, Y., Zhao, X., Liu, S., Ren, F., Zhang, Y., and Zhou, L. (2020). Metabolic Alterations Related to Glioma Grading Based on Metabolomics and Lipidomics Analyses. Metabolites, 10.","DOI":"10.3390\/metabo10120478"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.plipres.2013.08.004","article-title":"Interaction of brain fatty acid-binding protein with the polyunsaturated fatty acid environment as a potential determinant of poor prognosis in malignant glioma","volume":"52","author":"Elsherbiny","year":"2013","journal-title":"Prog. Lipid Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2174\/1570164611310030007","article-title":"Anti-cancer Therapies in High Grade Gliomas","volume":"10","author":"Tanase","year":"2013","journal-title":"Curr. Proteom."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.2147\/OTT.S52365","article-title":"Signal transduction molecule patterns indicating potential glioblastoma therapy approaches","volume":"6","author":"Tanase","year":"2013","journal-title":"Onco Targets Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrc3483","article-title":"Cancer metabolism: Fatty acid oxidation in the limelight","volume":"13","author":"Carracedo","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13148-017-0345-3","article-title":"Epigenetic changes in blood leukocytes following an omega-3 fatty acid supplementation","volume":"9","author":"Tremblay","year":"2017","journal-title":"Clin. Epigenetics"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s11101-019-09627-x","article-title":"Phytochemicals in cancer prevention: Modulating epigenetic alterations of DNA methylation","volume":"18","author":"Pop","year":"2019","journal-title":"Phytochem. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1046\/j.1471-4159.1998.71062528.x","article-title":"Fatty acid composition of human brain phospholipids during normal development","volume":"71","author":"Martinez","year":"1998","journal-title":"J. Neurochem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s12031-007-0060-1","article-title":"Brain uptake and utilization of fatty acids, lipids and lipoproteins: Application to neurological disorders","volume":"33","author":"Hamilton","year":"2007","journal-title":"J. Mol. Neurosci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1385\/JMN:16:2-3:87","article-title":"Brain uptake and utilization of fatty acids: Applications to peroxisomal biogenesis diseases","volume":"16","author":"Watkins","year":"2001","journal-title":"J. Mol. Neurosci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/(SICI)1097-4547(19990615)56:6<565::AID-JNR2>3.0.CO;2-H","article-title":"Essential fatty acids are mediators of brain biochemistry and cognitive functions","volume":"56","author":"Yehuda","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1111\/ejn.15147","article-title":"CD36\u2014A novel molecular target in the neurovascular unit","volume":"53","author":"Ioghen","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"20842","DOI":"10.1074\/jbc.M600627200","article-title":"Fibrillar beta-amyloid-stimulated intracellular signaling cascades require Vav for induction of respiratory burst and phagocytosis in monocytes and microglia","volume":"281","author":"Wilkinson","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-3-030-48457-6_8","article-title":"Thrombospondin in Tumor Microenvironment","volume":"1272","author":"Ramchandani","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5728438","DOI":"10.1155\/2016\/5728438","article-title":"Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets","volume":"2016","author":"Codrici","year":"2016","journal-title":"Stem Cells Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The Emerging Hallmarks of Cancer Metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41419-020-2449-5","article-title":"Enhanced fatty acid oxidation provides glioblastoma cells metabolic plasticity to accommodate to its dynamic nutrient microenvironment","volume":"11","author":"Kant","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","article-title":"Reprogramming of fatty acid metabolism in cancer","volume":"122","author":"Koundouros","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fcell.2017.00043","article-title":"Metabolic Reprogramming in Glioma","volume":"5","author":"Strickland","year":"2017","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1113\/JP278810","article-title":"Revisiting the Warburg effect: Historical dogma versus current understanding","volume":"599","author":"Vaupel","year":"2020","journal-title":"J. Physiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pharmthera.2015.05.003","article-title":"Metabolic consequences of oncogenic IDH mutations","volume":"152","author":"Parker","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"eaaw4543","DOI":"10.1126\/sciadv.aaw4543","article-title":"Cancer-associated mutation and beyond: The emerging biology of isocitrate dehydrogenases in human disease","volume":"5","author":"Murnan","year":"2019","journal-title":"Sci. Adv."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1038\/onc.2010.249","article-title":"Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas","volume":"29","author":"Bartkova","year":"2010","journal-title":"Oncogene"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41568-019-0226-5","article-title":"Altered cellular metabolism in gliomas\u2014An emerging landscape of actionable co-dependency targets","volume":"20","author":"Bi","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cmet.2020.06.002","article-title":"Targeting DGAT1 Ameliorates Glioblastoma by Increasing Fat Catabolism and Oxidative Stress","volume":"32","author":"Cheng","year":"2020","journal-title":"Cell Metab."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1158\/1535-7163.MCT-12-0095","article-title":"ATP citrate lyase knockdown induces growth arrest and apoptosis through different cell- and environment-dependent mechanisms","volume":"11","author":"Zaidi","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.cell.2014.11.025","article-title":"Acetate is a bioenergetic substrate for human glioblastoma and brain metastases","volume":"159","author":"Mashimo","year":"2014","journal-title":"Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/jcp.57.1.6","article-title":"The eicosanoid cascade: Possible role in gliomas and meningiomas","volume":"57","author":"Nathoo","year":"2004","journal-title":"J. Clin. Pathol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrn3820","article-title":"Polyunsaturated fatty acids and their metabolites in brain function and disease","volume":"15","author":"Bazinet","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1385\/JMN:16:2-3:195","article-title":"Polyunsaturated fatty acid synthesis and release by brain-derived cells in vitro","volume":"16","author":"Moore","year":"2001","journal-title":"J. Mol. Neurosci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0300-483X(00)00301-2","article-title":"A causal relationship between unscheduled eicosanoid signaling and tumor development: Cancer chemoprevention by inhibitors of arachidonic acid metabolism","volume":"153","author":"Marks","year":"2000","journal-title":"Toxicology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.cdd.4400711","article-title":"Ordering of ceramide formation, caspase activation, and Bax\/Bcl-2 expression during etoposide-induced apoptosis in C6 glioma cells","volume":"7","author":"Sawada","year":"2000","journal-title":"Cell Death Differ."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1038\/sj.onc.1203699","article-title":"Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells","volume":"19","author":"Sawada","year":"2000","journal-title":"Oncogene"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"19593","DOI":"10.1038\/s41598-019-55985-z","article-title":"Lipid accumulation and oxidation in glioblastoma multiforme","volume":"9","author":"Taib","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"101453","DOI":"10.1016\/j.isci.2020.101453","article-title":"Glioblastoma Utilizes Fatty Acids and Ketone Bodies for Growth Allowing Progression during Ketogenic Diet Therapy","volume":"23","author":"Sperry","year":"2020","journal-title":"iScience"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/MCO.0b013e32832182da","article-title":"Sterols in the central nervous system","volume":"12","author":"Mulder","year":"2009","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1158\/1078-0432.CCR-15-2973","article-title":"Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1-Mediated Lipogenesis","volume":"22","author":"Geng","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Ahmad, F., Sun, Q., Patel, D., and Stommel, J.M. (2019). Cholesterol Metabolism: A Potential Therapeutic Target in Glioblastoma. Cancers, 11.","DOI":"10.3390\/cancers11020146"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/02688699746276","article-title":"Increased levels of cholesterol esters in glioma tissue and surrounding areas of human brain","volume":"11","author":"Nygren","year":"1997","journal-title":"Br. J. Neurosurg."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/1574892812666171129141211","article-title":"Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins","volume":"13","author":"Iannelli","year":"2018","journal-title":"Recent Pat. Anticancer. Drug. Discov."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s13046-021-02041-2","article-title":"Statins: A repurposed drug to fight cancer","volume":"40","author":"Jiang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00280-009-1041-6","article-title":"A phase I\/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: Clinical outcomes, pharmacokinetics and molecular correlation","volume":"65","author":"Thiessen","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"ra82","DOI":"10.1126\/scisignal.2000446","article-title":"EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy","volume":"2","author":"Guo","year":"2009","journal-title":"Sci. Signal."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nrc.2016.89","article-title":"The multifaceted roles of fatty acid synthesis in cancer","volume":"16","author":"Rohrig","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/019459988709700413","article-title":"Arachnoid cyst manifested as an ethmoid mass with cerebrospinal fluid rhinorrhea","volume":"97","author":"Toriumi","year":"1987","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.trecan.2015.10.009","article-title":"Glioblastoma: Defining Tumor Niches","volume":"1","author":"Hambardzumyan","year":"2015","journal-title":"Trends Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Monteiro, A.R., Hill, R., Pilkington, G.J., and Madureira, P.A. (2017). The Role of Hypoxia in Glioblastoma Invasion. Cells, 6.","DOI":"10.3390\/cells6040045"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.celrep.2014.08.056","article-title":"Fatty acid uptake and lipid storage induced by HIF-1alpha contribute to cell growth and survival after hypoxia-reoxygenation","volume":"9","author":"Bensaad","year":"2014","journal-title":"Cell Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/nbm.2794","article-title":"Metabolism of [U-13 C]glucose in human brain tumors in vivo","volume":"25","author":"Maher","year":"2012","journal-title":"NMR Biomed."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cmet.2019.04.004","article-title":"Acyl-CoA-Binding Protein Drives Glioblastoma Tumorigenesis by Sustaining Fatty Acid Oxidation","volume":"30","author":"Duman","year":"2019","journal-title":"Cell Metab."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cmet.2019.07.007","article-title":"Acyl-CoA-Binding Protein Fuels Gliomagenesis","volume":"30","author":"Bi","year":"2019","journal-title":"Cell Metab."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e1543","DOI":"10.1038\/cddis.2014.509","article-title":"Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: Possible involvement in radioresistance","volume":"5","author":"Dahan","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1158\/1535-7163.MCT-15-0675","article-title":"Dedifferentiation of Glioma Cells to Glioma Stem-like Cells By Therapeutic Stress-induced HIF Signaling in the Recurrent GBM Model","volume":"15","author":"Lee","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e98772","DOI":"10.15252\/embj.201798772","article-title":"Infiltrative and drug-resistant slow-cycling cells support metabolic heterogeneity in glioblastoma","volume":"37","author":"Siebzehnrubl","year":"2018","journal-title":"EMBO J."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Caragher, S., Miska, J., Shireman, J., Park, C.H., Muroski, M., Lesniak, M.S., and Ahmed, U. (2020). Temozolomide Treatment Increases Fatty Acid Uptake in Glioblastoma Stem Cells. Cancers, 12.","DOI":"10.3390\/cancers12113126"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/jim-2018-000962","article-title":"Targeting cholesterol metabolism in glioblastoma: A new therapeutic approach in cancer therapy","volume":"67","author":"Pirmoradi","year":"2019","journal-title":"J. Investig. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/j.bbagen.2017.06.007","article-title":"Glycolipids: Essential regulator of neuro-inflammation, metabolism and gliomagenesis","volume":"1861","author":"Furukawa","year":"2017","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0005-2736(77)90025-6","article-title":"Isolation of the membrane glycoproteins of human blood platelets by lectin affinity chromatography","volume":"464","author":"Clemetson","year":"1977","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"re3","DOI":"10.1126\/scisignal.272re3","article-title":"CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior","volume":"2","author":"Silverstein","year":"2009","journal-title":"Sci. Signal."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/stem.1716","article-title":"Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression","volume":"32","author":"Hale","year":"2014","journal-title":"Stem Cells"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.stem.2010.02.018","article-title":"Integrin alpha 6 regulates glioblastoma stem cells","volume":"6","author":"Lathia","year":"2010","journal-title":"Cell Stem Cell"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00109-008-0357-8","article-title":"The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells","volume":"86","author":"Bidlingmaier","year":"2008","journal-title":"J. Mol. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s40478-021-01205-7","article-title":"Altered lipid metabolism marks glioblastoma stem and non-stem cells in separate tumor niches","volume":"9","author":"Shakya","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1158\/0008-5472.CAN-03-2073","article-title":"Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population","volume":"64","author":"Brat","year":"2004","journal-title":"Cancer Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/nm.3337","article-title":"CSF-1R inhibition alters macrophage polarization and blocks glioma progression","volume":"19","author":"Pyonteck","year":"2013","journal-title":"Nat. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ccell.2017.07.006","article-title":"Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade","volume":"32","author":"Saha","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Roesch, S., Rapp, C., Dettling, S., and Herold-Mende, C. (2018). When Immune Cells Turn Bad-Tumor-Associated Microglia\/Macrophages in Glioma. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19020436"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3389\/fphar.2020.00368","article-title":"Targeting Tumor Associated Macrophages to Overcome Conventional Treatment Resistance in Glioblastoma","volume":"11","author":"Gregoire","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1006\/exnr.1999.7276","article-title":"Oxidized high-density lipoprotein induces neuron death","volume":"161","author":"Keller","year":"2000","journal-title":"Exp. Neurol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1158\/0008-5472.CAN-19-2994","article-title":"Enhanced Lipid Accumulation and Metabolism Are Required for the Differentiation and Activation of Tumor-Associated Macrophages","volume":"80","author":"Su","year":"2020","journal-title":"Cancer Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13059-017-1362-4","article-title":"Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment","volume":"18","author":"Muller","year":"2017","journal-title":"Genome Biol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Hale, J.S., Li, M., Sinyuk, M., Jahnen-Dechent, W., Lathia, J.D., and Silverstein, R.L. (2012). Context dependent role of the CD36\u2014thrombospondin\u2014histidine-rich glycoprotein axis in tumor angiogenesis and growth. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0040033"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1158\/0008-5472.CAN-08-1166","article-title":"Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism","volume":"69","author":"Kaur","year":"2009","journal-title":"Cancer Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.matbio.2014.01.012","article-title":"Current understanding of the thrombospondin-1 interactome","volume":"37","author":"Resovi","year":"2014","journal-title":"Matrix Biol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"84546","DOI":"10.18632\/oncotarget.19165","article-title":"Thrombospondin-1 is a multifaceted player in tumor progression","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_85","first-page":"296069","article-title":"Thrombospondin-1: Multiple paths to inflammation","volume":"2011","author":"Pidcock","year":"2011","journal-title":"Mediat. Inflamm."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.2174\/1381612826666200128091506","article-title":"Thrombospondin-1 as a Potential Therapeutic Target: Multiple Roles in Cancers","volume":"26","author":"Wang","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/jcp.21281","article-title":"Syndecan-4 contributes to endothelial tubulogenesis through interactions with two motifs inside the pro-angiogenic N-terminal domain of thrombospondin-1","volume":"214","author":"Nunes","year":"2008","journal-title":"J. Cell. Physiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/71517","article-title":"Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1","volume":"6","author":"Jimenez","year":"2000","journal-title":"Nat. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.cell.2009.09.025","article-title":"Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis","volume":"139","author":"Eroglu","year":"2009","journal-title":"Cell"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.biocel.2007.10.002","article-title":"Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain","volume":"40","author":"Margosio","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/s41467-019-08480-y","article-title":"Deciphering the complex role of thrombospondin-1 in glioblastoma development","volume":"10","author":"Daubon","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1161\/01.STR.0000047100.84604.BA","article-title":"Differential regulation of thrombospondin-1 and thrombospondin-2 after focal cerebral ischemia\/reperfusion","volume":"34","author":"Lin","year":"2003","journal-title":"Stroke"},{"key":"ref_93","first-page":"1191","article-title":"Overexpression of thrombospondin-1 reduces growth and vascular index but not perfusion in glioblastoma","volume":"62","author":"Kragh","year":"2002","journal-title":"Cancer Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/carcin\/bgaa052","article-title":"Glioma-derived extracellular vesicles promote tumor progression by conveying WT1","volume":"41","author":"Tsutsui","year":"2020","journal-title":"Carcinogenesis"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1084\/jem.191.10.1789","article-title":"Thrombospondin-1 is downregulated by anoxia and suppresses tumorigenicity of human glioblastoma cells","volume":"191","author":"Tenan","year":"2000","journal-title":"J. Exp. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0304-3835(02)00592-X","article-title":"Introduction of wild-type p53 enhances thrombospondin-1 expression in human glioma cells","volume":"191","author":"Harada","year":"2003","journal-title":"Cancer Lett."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/mt.2014.214","article-title":"Antiangiogenic variant of TSP-1 targets tumor cells in glioblastomas","volume":"23","author":"Choi","year":"2015","journal-title":"Mol. Ther."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1038\/sj.onc.1207438","article-title":"Expression of the thrombospondin 1 fragment 167-569 in C6 glioma cells stimulates tumorigenicity despite reduced neovascularization","volume":"23","author":"Keramidas","year":"2004","journal-title":"Oncogene"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11060-010-0284-8","article-title":"Identification of diagnostic serum protein profiles of glioblastoma patients","volume":"102","author":"Elstner","year":"2011","journal-title":"J. Neuro-Oncol."},{"key":"ref_100","first-page":"22","article-title":"Thrombospondin-1 is a prognostic biomarker and is correlated with tumor immune microenvironment in glioblastoma","volume":"21","author":"Qi","year":"2021","journal-title":"Oncol. Lett."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/10409238.2015.1014024","article-title":"CD47 signaling pathways controlling cellular differentiation and responses to stress","volume":"50","author":"Kaur","year":"2015","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"14991","DOI":"10.1074\/jbc.M110.179663","article-title":"Heparan sulfate modification of the transmembrane receptor CD47 is necessary for inhibition of T cell receptor signaling by thrombospondin-1","volume":"286","author":"Kaur","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e1391973","DOI":"10.1080\/2162402X.2017.1391973","article-title":"Blocking the CD47-SIRPalpha axis by delivery of anti-CD47 antibody induces antitumor effects in glioma and glioma stem cells","volume":"7","author":"Li","year":"2018","journal-title":"Oncoimmunology"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Zhang, M., Hutter, G., Kahn, S.A., Azad, T.D., Gholamin, S., Xu, C.Y., Liu, J., Achrol, A.S., Richard, C., and Sommerkamp, P. (2016). Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0153550"},{"key":"ref_105","first-page":"264124","article-title":"Microglia and macrophages in malignant gliomas: Recent discoveries and implications for promising therapies","volume":"2013","author":"Badie","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13045-016-0381-z","article-title":"Is CD47 an innate immune checkpoint for tumor evasion?","volume":"10","author":"Liu","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.immuni.2020.07.008","article-title":"CD47 Ligation Repositions the Inhibitory Receptor SIRPA to Suppress Integrin Activation and Phagocytosis","volume":"53","author":"Morrissey","year":"2020","journal-title":"Immunity"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"6662","DOI":"10.1073\/pnas.1121623109","article-title":"The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors","volume":"109","author":"Willingham","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"eaaf2968","DOI":"10.1126\/scitranslmed.aaf2968","article-title":"Disrupting the CD47-SIRPalpha anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors","volume":"9","author":"Gholamin","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"63ra94","DOI":"10.1126\/scitranslmed.3001375","article-title":"Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47","volume":"2","author":"Chao","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/s41467-020-15129-8","article-title":"Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/1753425919876690","article-title":"Irradiation or temozolomide chemotherapy enhances anti-CD47 treatment of glioblastoma","volume":"26","author":"Gholamin","year":"2020","journal-title":"Innate Immun."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s00262-020-02806-2","article-title":"CD47 expression in gastric cancer clinical correlates and association with macrophage infiltration","volume":"70","author":"Shi","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF01307185","article-title":"Thrombospondin as a mediator of cancer cell adhesion in metastasis","volume":"11","author":"Walz","year":"1992","journal-title":"Cancer Metastasis Rev."},{"key":"ref_115","first-page":"1735","article-title":"Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells","volume":"57","author":"Guo","year":"1997","journal-title":"Cancer Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1365-2990.2010.01069.x","article-title":"Review: On TRAIL for malignant glioma therapy?","volume":"36","author":"Kuijlen","year":"2010","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.7150\/thno.36037","article-title":"CD36 tango in cancer: Signaling pathways and functions","volume":"9","author":"Wang","year":"2019","journal-title":"Theranostics"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1182\/blood-2013-01-482315","article-title":"Thrombospondin-1 modulates VEGF signaling via CD36 by recruiting SHP-1 to VEGFR2 complex in microvascular endothelial cells","volume":"122","author":"Chu","year":"2013","journal-title":"Blood"},{"key":"ref_119","first-page":"593","article-title":"Histidine rich glycoprotein and cancer: A multi-faceted relationship","volume":"34","author":"Johnson","year":"2014","journal-title":"Anticancer. Res."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Jones, C., K\u00e4rrlander, M., Lindberg, N., Olofsson, T., Kastemar, M., Olsson, A.-K., and Uhrbom, L. (2009). Histidine-Rich Glycoprotein Can Prevent Development of Mouse Experimental Glioblastoma. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0008536"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/imr.12527","article-title":"The CD47-SIRPalpha signaling axis as an innate immune checkpoint in cancer","volume":"276","author":"Matlung","year":"2017","journal-title":"Immunol. Rev."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.mvr.2007.04.007","article-title":"Thrombospondin-based antiangiogenic therapy","volume":"74","author":"Zhang","year":"2007","journal-title":"Microvasc. Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4161\/cc.10.1.14324","article-title":"CD47 applies the brakes to angiogenesis via vascular endothelial growth factor receptor-2","volume":"10","author":"Kaur","year":"2011","journal-title":"Cell Cycle"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Falero-Perez, J., Song, Y.S., Zhao, Y., Teixeira, L., Sorenson, C.M., and Sheibani, N. (2018). Cyp1b1 expression impacts the angiogenic and inflammatory properties of liver sinusoidal endothelial cells. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0206756"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"38923","DOI":"10.1074\/jbc.M110.172304","article-title":"Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47","volume":"285","author":"Kaur","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nrc2561","article-title":"Regulation of nitric oxide signalling by thrombospondin 1: Implications for anti-angiogenic therapies","volume":"9","author":"Isenberg","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.niox.2009.05.005","article-title":"Thrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation","volume":"21","author":"Isenberg","year":"2009","journal-title":"Nitric Oxide"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"19684","DOI":"10.1038\/srep19684","article-title":"Secreted Thrombospondin-1 Regulates Macrophage Interleukin-1beta Production and Activation through CD47","volume":"6","author":"Stein","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1074\/jbc.M804860200","article-title":"Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responses","volume":"284","author":"Isenberg","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s00018-007-7488-x","article-title":"Thrombospondin-1: A physiological regulator of nitric oxide signaling","volume":"65","author":"Isenberg","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1096\/fj.09-131649","article-title":"Thrombospondin-1 modulates vascular endothelial growth factor activity at the receptor level","volume":"23","author":"Zhang","year":"2009","journal-title":"FASEB J."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1083\/jcb.138.3.707","article-title":"CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells","volume":"138","author":"Dawson","year":"1997","journal-title":"J. Cell Biol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"614619","DOI":"10.1155\/2013\/614619","article-title":"CD47: A Cell Surface Glycoprotein Which Regulates Multiple Functions of Hematopoietic Cells in Health and Disease","volume":"2013","author":"Oldenborg","year":"2013","journal-title":"ISRN Hematol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2176\/nmc.35.423","article-title":"Secretion of Transforming Growth Factor-\u03b21 and -\u03b22 by Malignant Glioma Cells","volume":"35","author":"Sasaki","year":"1995","journal-title":"Neurol. Med.-Chir."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"26069","DOI":"10.1074\/jbc.M605040200","article-title":"CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1","volume":"281","author":"Isenberg","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.4049\/jimmunol.1303116","article-title":"CD47 signaling regulates the immunosuppressive activity of VEGF in T cells","volume":"193","author":"Kaur","year":"2014","journal-title":"J. Immunol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"a006627","DOI":"10.1101\/cshperspect.a006627","article-title":"Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2","volume":"2","author":"Lawler","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1023\/A:1009018702832","article-title":"Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: Effect on human microvascular endothelial cell proliferation and angiogenesis","volume":"3","author":"Gupta","year":"1999","journal-title":"Angiogenesis"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"15404","DOI":"10.1074\/jbc.M701638200","article-title":"Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake","volume":"282","author":"Isenberg","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrc3640","article-title":"Tetraspanin proteins promote multiple cancer stages","volume":"14","author":"Hemler","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tcb.2020.11.004","article-title":"Dynamic Plasma Membrane Organization: A Complex Symphony","volume":"31","author":"Arp","year":"2021","journal-title":"Trends Cell Biol."},{"key":"ref_142","first-page":"653","article-title":"Function and Dynamics of Tetraspanins during Antigen Recognition and Immunological Synapse Formation","volume":"6","year":"2015","journal-title":"Front. Immunol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.4049\/jimmunol.154.5.2366","article-title":"Proinflammatory cytokines potentiate thrombospondin-mediated phagocytosis of neutrophils undergoing apoptosis","volume":"154","author":"Ren","year":"1995","journal-title":"J. Immunol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1096\/fj.05-3697fje","article-title":"Identification of CD36 molecular features required for its in vitro angiostatic activity","volume":"19","author":"Primo","year":"2005","journal-title":"FASEB J."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fphar.2015.00252","article-title":"Original insights on thrombospondin-1-related antireceptor strategies in cancer","volume":"6","author":"Jeanne","year":"2015","journal-title":"Front. Pharmacol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/7801202","article-title":"Targeting CD36 as Biomarker for Metastasis Prognostic: How Far from Translation into Clinical Practice?","volume":"2018","author":"Enciu","year":"2018","journal-title":"BioMed Res. Int."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fimmu.2020.00018","article-title":"Advances in Anti-Tumor Treatments Targeting the CD47\/SIRP\u03b1 Axis","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_148","first-page":"179","article-title":"Preclinical and clinical development of therapeutic antibodies targeting functions of CD47 in the tumor microenvironment","volume":"3","author":"Kaur","year":"2020","journal-title":"Antib. Ther."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"42859","DOI":"10.1074\/jbc.M206849200","article-title":"Regulation of integrin function by CD47 ligands. Differential effects on alpha vbeta 3 and alpha 4beta1 integrin-mediated adhesion","volume":"277","author":"Barazi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1182\/blood.V98.12.3346","article-title":"C-terminal peptide of thrombospondin-1 induces platelet aggregation through the Fc receptor gamma-chain-associated signaling pathway and by agglutination","volume":"98","author":"Tulasne","year":"2001","journal-title":"Blood"},{"key":"ref_151","first-page":"1429","article-title":"Thrombospondin-1 receptor mediates autophagy of RAS-expressing cancer cells and triggers tumour growth inhibition","volume":"33","author":"Kalas","year":"2013","journal-title":"Anticancer. Res."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Leclair, P., and Lim, C.J. (2014). CD47-independent effects mediated by the TSP-derived 4N1K peptide. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0098358"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"17981","DOI":"10.18632\/oncotarget.4025","article-title":"Identification of TAX2 peptide as a new unpredicted anti-cancer agent","volume":"6","author":"Jeanne","year":"2015","journal-title":"Oncotarget"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Jeanne, A., Sarazin, T., Charle, M., Moali, C., Fichel, C., Boulagnon-Rombi, C., Callewaert, M., Andry, M.-C., Diesis, E., and Delolme, F. (2021). Targeting Ovarian Carcinoma with TSP-1:CD47 Antagonist TAX2 Activates Anti-Tumor Immunity. Cancers, 13.","DOI":"10.3390\/cancers13195019"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"662","DOI":"10.18632\/oncotarget.200","article-title":"Targeting tumor angiogenesis with TSP-1-based compounds: Rational design of antiangiogenic mimetics of endogenous inhibitors","volume":"1","author":"Taraboletti","year":"2010","journal-title":"Oncotarget"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"8733","DOI":"10.1074\/jbc.M109.085605","article-title":"Non-peptidic thrombospondin-1 mimics as fibroblast growth factor-2 inhibitors: An integrated strategy for the development of new antiangiogenic compounds","volume":"285","author":"Colombo","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Pagano, K., Torella, R., Foglieni, C., Bugatti, A., Tomaselli, S., Zetta, L., Presta, M., Rusnati, M., Taraboletti, G., and Colombo, G. (2012). Direct and allosteric inhibition of the FGF2\/HSPGs\/FGFR1 ternary complex formation by an antiangiogenic, thrombospondin-1-mimic small molecule. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0036990"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Meli, M., Pagano, K., Ragona, L., and Colombo, G. (2014). Investigating the dynamic aspects of drug-protein recognition through a combination of MD and NMR analyses: Implications for the development of protein-protein interaction inhibitors. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0097153"},{"key":"ref_159","first-page":"A399","article-title":"374 A first-in-human Phase 1\/2 open label trial evaluating the safety, pharmacology, and preliminary efficacy of VT1021 in subjects with advanced solid tumors","volume":"8","author":"Mahalingam","year":"2020","journal-title":"J. ImmunoTherapy Cancer"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-021-01197-w","article-title":"Targeting CD47 for cancer immunotherapy","volume":"14","author":"Jiang","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"12650","DOI":"10.1074\/jbc.M115.648220","article-title":"\u201cVelcro\u201d engineering of high affinity CD47 ectodomain as signal regulatory protein alpha (SIRPalpha) antagonists that enhance antibody-dependent cellular phagocytosis","volume":"290","author":"Ho","year":"2015","journal-title":"J. Biol. Chem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/2\/604\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:00:33Z","timestamp":1760364033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/2\/604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,6]]},"references-count":161,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["ijms23020604"],"URL":"https:\/\/doi.org\/10.3390\/ijms23020604","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,6]]}}}